Kevin McLaughlin
Patrimonio netto: 778 062 $ in data 30/09/2026
Patrimonio netto: 778 062 $ in data 30/09/2026
Fondatore di Aptius Education, Inc., Kevin F. McLaughlin è attualmente direttore finanziario, tesoriere e vicepresidente senior di Acceleron Pharma, Inc. È anche nel consiglio di Vericel Corp., Stealth BioTherapeutics Corp. e Stealth BioTherapeutics, Inc. Nella sua carriera passata ha occupato la posizione di direttore operativo e direttore di Aptius Education, Inc., direttore finanziario e vicepresidente senior di Qteros, Inc., direttore esecutivo e direttore di Praecis Pharmaceuticals, Inc., direttore finanziario e vicepresidente di Advanced TechCom, Inc., tesoriere e vicepresidente di Computervision Corp. e tesoriere e vicepresidente di Prime Computer, Inc. Kevin F. McLaughlin ha conseguito una laurea presso la Northeastern University e un MBA presso il Babson College.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
VERICEL CORPORATION 0,04% | 12/08/2026 | 18.300 ( 0,04% ) | 734 562 $ | 30/09/2026 |
INVIVYD, INC. 0,02% | 19/05/2026 | 50.000 ( 0,02% ) | 43 500 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| VERICEL CORPORATION | Direttore/Membro del Consiglio | 06/01/2015 |
| STEALTH BIOTHERAPEUTICS CORP | Direttore/Membro del Consiglio | 14/03/2017 |
| INVIVYD, INC. | Direttore/Membro del Consiglio | 21/05/2024 |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Direttore/Membro del Consiglio | 01/03/2017 |
Combined Therapeutics, Inc.
Combined Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a pre-clinical-stage biotechnology company in the cancer research | Direttore/Membro del Consiglio | 08/03/2023 |
| Società | Posizione | Fine |
|---|---|---|
| DECIBEL THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 22/09/2023 |
| ACCELERON PHARMA INC. | Direttore Finanziario/CFO | 01/12/2021 |
Qteros, Inc.
Qteros, Inc. Chemicals: SpecialtyProcess Industries Develops cellulosic ethanol transportation fuel | Direttore Finanziario/CFO | - |
Aptius Education, Inc. | Fondatore | 01/01/2009 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 15 |
|---|---|
Computervision R&D, Inc.
Computervision R&D, Inc. Packaged SoftwareTechnology Services Provides electronic product definition solutions | Technology Services |
Vericel Corp.
Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies for the treatment of cancer | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Prime Computer, Inc.
Prime Computer, Inc. Computer Processing HardwareElectronic Technology Manufactures and sells computer and electronic components | Electronic Technology |
Advanced TechCom, Inc.
Advanced TechCom, Inc. Telecommunications EquipmentElectronic Technology Designs, manufactures and markets a line of digital microwave and millimeterwave radio systems | Electronic Technology |
Babson College
Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Qteros, Inc.
Qteros, Inc. Chemicals: SpecialtyProcess Industries Develops cellulosic ethanol transportation fuel | Process Industries |
Aptius Education, Inc. | |
Decibel Therapeutics, Inc.
Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Combined Therapeutics, Inc.
Combined Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a pre-clinical-stage biotechnology company in the cancer research | Commercial Services |
Stealth BioTherapeutics Corp.
Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops investigational drugs for the treatment of diseases involving mitochondrial dysfunction | Health Technology |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Health Technology |
Invivyd, Inc.
Invivyd, Inc. BiotechnologyHealth Technology Develops antibody-based solutions for infectious diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale